Merck & Co Inc (NYSE:MRK) price on Thursday, May 09, rose 0.08% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $129.66.
A look at the stock’s price movement, the level at last check in today’s session was $129.55. The PE ratio in trailing twelve months stood at 144.34. Turning to its 52-week performance, $133.10 and $99.14 were the 52-week high and 52-week low respectively. Overall, MRK moved 2.30% over the past month.
Merck & Co Inc’s market cap currently stands at around $328.40 billion. The company has a Forward Dividend ratio of 3.00, with its dividend yield at 2.31%. As such, investors might be keen on an upside in the stock’s price ahead of the scheduled earnings report.
Analysts have a consensus estimate of 15.8B for the company’s revenue for the quarter, with a low and high estimate of 15.4B and 16.13B respectively. The average forecast suggests up to a 5.10% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 64.26B, representing a 6.90% jump on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that MRK is a 100% Buy. On the other hand, the stock is on average a 100% Buy as suggested by medium term indicators while long term indicators are putting the stock in 100% Buy category.
The technical evaluation for the stock shows the PEG ratio is 2.16, with MRK’s current price about 1.55% and 2.58% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 57.78, while 7-day volatility ratio is 1.49% and 1.53% in the 30-day chart. Further, Merck & Co Inc (MRK) has a beta value of 0.42, and an average true range (ATR) of 2.05.
If we refocus on Merck & Co Inc (NYSE:MRK), historical trading data shows that trading volumes averaged 8.19 million over the past 3 months. The company’s latest data on shares outstanding shows there are 2.53 billion shares.
The 0.13% of Merck & Co Inc’s shares are in the hands of company insiders while institutional holders own 78.62% of the company’s shares. Current price change has pushed the stock 18.93% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the MRK stock continues to rise going into the next quarter.
